Reuters logo
BRIEF-North China Pharmaceutical receives GMP certificate
March 22, 2017 / 9:42 AM / 6 months ago

BRIEF-North China Pharmaceutical receives GMP certificate

March 22 (Reuters) - North China Pharmaceutical Co Ltd :

* Says it received goods manufacture practice(GMP) certificate from Hebei Food and Drug Administration on March 21

* Certificate issued to production line for manufacturing Amoxicillin Dispersible tablets, Amoxicillin and Clavulanate Potassium tablets and Amoxil capsule

* Valid until Feb. 23, 2022

Source text in Chinese: goo.gl/fPDlA2

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below